Bioelectronics Corp (BIEL)

[srinsocal]

Yes, ancient history, all the way back to December 2022

Done by a team of 12 UCSD Doctors.

Brian M. Ilfeld MD, MS (Clinical Investigation)
Engy T. Said MD
Rodney A. Gabriel MD, MAS (Clinical Research)
Brian P. Curran MD
Matthew W. Swisher MD
MS, Garth R. Jacobsen MD
Anne M. Wallace MD
Jay Doucet MD, FRCSC, FACS
Laura M. Adams MD, George J. Ventro MD
Baharin Abdullah MD
John J. Finneran IV MD

I will go with the findings and the opinion of Dr Brian Ilfeld, who has done dozens and dozens of clinical studies,

"Six patients avoided opioid use entirely, while the remaining individual required only 5 mg of oxycodone during the first postoperative day."

"These cases demonstrate that the ambulatory use of pulsed shortwave devices is feasible and may be an effective analgesic, possibly obviating opioid requirements following outpatient herniorrhaphy and breast surgery. Considering the lack of any side effects, adverse events, and misuse/dependence/diversion potential, further study with a randomized, controlled trial appears warranted."

https://onlinelibrary.wiley.com/doi/10.1111/papr.13188